FDA Asks Sarepta to Halt Gene Therapy After Three Deaths
Sarepta Therapeutics is in hot water with the FDA and its stock has been hammered after three deaths were reportedly linked to its Elevidys muscular dystrophy gene therapy. As reported by Bloomberg: Two teenage boys died of acute liver failure in recent months after taking Elevidys. They were being treated for Duchenne muscular dystrophy and […]
Discuss on Nostr!
Nostr Note ID note1e6z3pddps699runwupamt7fxtwj9gg0a43ss478ew05e3wr3577s6kuapm Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.